Dentists in Morgan City, LA Accepting Medicare
9 Dentists found. Showing 1 - 9
 Dr. Frank J. Distefano, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1016 David Dr, Morgan City, LA 70380 Phone: 985-384-6907 Fax: 985-384-6953 |
Dr. Robert Arman Adams Iii, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1407 South Rd, Morgan City, LA 70380 Phone: 985-395-2436 Fax: 985-395-2491 |
 Dr. Jane M. Birriel, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1151 Marguerite St, Suite 100a, Morgan City, LA 70380 Phone: 985-385-2992 Fax: 985-385-2994 |
Dr. Bruce J Leblanc, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1234 David Dr, Suite 105, Morgan City, LA 70380 Phone: 985-385-3707 |
Dr. Peter Scott Guidry, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1234 David Dr, Suite 106, Morgan City, LA 70380 Phone: 985-385-5423 |
Dr. Dean Leonard Listi, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 904 David Dr, Morgan City, LA 70380 Phone: 985-384-4044 Fax: 985-384-4043 |
Dr. Charles Henry Broussard, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1255 Belleview St, Morgan City, LA 70380 Phone: 985-395-4100 |
Dr. Charles Leonard Wise, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1200 Victor Ii Blvd, Morgan City, LA 70380 Phone: 985-384-0926 Fax: 985-384-6754 |
Dr. Whybra Joseph Duay Jr., D.D.S. Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 1301 Victor Ii Blvd, Morgan City, LA 70380 Phone: 985-385-1850 Fax: 985-385-6371 |
News Archive
FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers
FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.
Scientists identify potential therapeutic targets to alleviate severe COVID-19 in aged patients
The scientists assessed epidemiological data from March to December 2020 from the CDC to investigate the prevalence of COVID-19 disease among different age groups.
Researchers gain new insight into fragile X syndrome
Scientists have gained new insight into fragile X syndrome - the most common cause of inherited intellectual disability - by studying the case of a person without the disorder, but with two of its classic symptoms.
Medicare prescription drug benefit did not save any money overall, say researchers
For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky Briesacher challenges that assumption and suggests that the U.S. Congressional Budget Office's adopted a new costing method based on assumed cost-savings may be "premature."
› Verified 4 days ago
Pharmacists
Counselors
Dentists
Clinical Social Workers
Occupational Therapists
Psychologists